Altogether, Nrf2 may represent a very effective and potent therapeutic target for glioma and pharmacological inhibitors of Nrf2 may serve as a useful adjunct to Carmustine for the treatment of malignant glioma. The gene discussed is NFE2L2; the disease is glioma.